These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 30736475)

  • 101. Single Nucleotide Polymorphisms as Prognostic and Predictive Factors of Adjuvant Chemotherapy in Colorectal Cancer of Stages I and II.
    Horvat M; Potočnik U; Repnik K; Kavalar R; Štabuc B
    Gastroenterol Res Pract; 2016; 2016():2139489. PubMed ID: 26884752
    [TBL] [Abstract][Full Text] [Related]  

  • 102. MicroRNA-Based Therapeutics for Drug-Resistant Colorectal Cancer.
    Jung E; Choi J; Kim JS; Han TS
    Pharmaceuticals (Basel); 2021 Feb; 14(2):. PubMed ID: 33567635
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Prognostic value of colorectal cancer biomarkers.
    Bianchi P; Laghi L; Delconte G; Malesci A
    Cancers (Basel); 2011 Apr; 3(2):2080-105. PubMed ID: 24212797
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Molecular Landscape and Treatment Options for Patients with Metastatic Colorectal Cancer.
    Miyamoto Y; Zhang W; Lenz HJ
    Indian J Surg Oncol; 2017 Dec; 8(4):580-590. PubMed ID: 29203992
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Circulating microRNAs as Prognostic and Predictive Biomarkers in Patients with Colorectal Cancer.
    Schou JV; Johansen JS; Nielsen D; Rossi S
    Noncoding RNA; 2016 Jun; 2(2):. PubMed ID: 29657263
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Interleukins (Cytokines) as Biomarkers in Colorectal Cancer: Progression, Detection, and Monitoring.
    Maryam S; Krukiewicz K; Haq IU; Khan AA; Yahya G; Cavalu S
    J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176567
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Promising Colorectal Cancer Biomarkers for Precision Prevention and Therapy.
    Turano M; Delrio P; Rega D; Cammarota F; Polverino A; Duraturo F; Izzo P; De Rosa M
    Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31817090
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Recent Approaches on Molecular Markers, Treatment and Novel Drug Delivery System Used for the Management of Colorectal Cancer: A Comprehensive Review.
    Chauhan S; Sharma S
    Curr Pharm Biotechnol; 2024 Jan; ():. PubMed ID: 38275054
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Molecular Network of Colorectal Cancer and Current Therapeutic Options.
    Huang Z; Yang M
    Front Oncol; 2022; 12():852927. PubMed ID: 35463300
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Deconvoluting the complexity of autophagy in colorectal cancer: From crucial pathways to targeted therapies.
    Qiang L; Li H; Wang Z; Wan L; Jiang G
    Front Oncol; 2022; 12():1007509. PubMed ID: 36172152
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives.
    Pellino G; Gallo G; Pallante P; Capasso R; De Stefano A; Maretto I; Malapelle U; Qiu S; Nikolaou S; Barina A; Clerico G; Reginelli A; Giuliani A; Sciaudone G; Kontovounisios C; Brunese L; Trompetto M; Selvaggi F
    Gastroenterol Res Pract; 2018; 2018():2397863. PubMed ID: 30008744
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Regulation of signal transduction pathways in colorectal cancer: implications for therapeutic resistance.
    Yeoh Y; Low TY; Abu N; Lee PY
    PeerJ; 2021; 9():e12338. PubMed ID: 34733591
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Incorporating Novel Technologies in Precision Oncology for Colorectal Cancer: Advancing Personalized Medicine.
    Ahluwalia P; Ballur K; Leeman T; Vashisht A; Singh H; Omar N; Mondal AK; Vaibhav K; Baban B; Kolhe R
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339232
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging.
    Corrias G; Lai E; Ziranu P; Mariani S; Donisi C; Liscia N; Saba G; Pretta A; Persano M; Fanni D; Spanu D; Balconi F; Loi F; Deidda S; Restivo A; Pusceddu V; Puzzoni M; Solinas C; Massa E; Madeddu C; Gerosa C; Zorcolo L; Faa G; Saba L; Scartozzi M
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611042
    [TBL] [Abstract][Full Text] [Related]  

  • 115. TRIM Proteins in Colorectal Cancer: TRIM8 as a Promising Therapeutic Target in Chemo Resistance.
    Marzano F; Caratozzolo MF; Pesole G; Sbisà E; Tullo A
    Biomedicines; 2021 Feb; 9(3):. PubMed ID: 33673719
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Molecular Landscape and Therapeutic Strategies against Colorectal Cancer.
    Patel A; Gulhati P
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672633
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Chromatin factors: Ready to roll as biomarkers in metastatic colorectal cancer?
    Moreta-Moraleda C; Queralt C; Vendrell-Ayats C; Forcales S; Martínez-Balibrea E
    Pharmacol Res; 2023 Oct; 196():106924. PubMed ID: 37709185
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Diagnostic and therapeutic biomarkers in colorectal cancer: a review.
    de Assis JV; Coutinho LA; Oyeyemi IT; Oyeyemi OT; Grenfell RFEQ
    Am J Cancer Res; 2022; 12(2):661-680. PubMed ID: 35261794
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Colorectal Cancer Biomarkers in the Era of Personalized Medicine.
    Patel JN; Fong MK; Jagosky M
    J Pers Med; 2019 Jan; 9(1):. PubMed ID: 30646508
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Updates on Clinical Use of Liquid Biopsy in Colorectal Cancer Screening, Diagnosis, Follow-Up, and Treatment Guidance.
    Mazouji O; Ouhajjou A; Incitti R; Mansour H
    Front Cell Dev Biol; 2021; 9():660924. PubMed ID: 34150757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.